Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIGER-1: LSAM-Cisplatin in Diffuse Midline Glioma
NCT07767110Phase 2Not yet recruiting
- Sponsor
- NanOlogy
- Start
- Dec 2026
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of LSAM-Cisplatin in diffuse midline glioma (DMG), diffuse intrinsic pontine glioma (DIPG), sponsored by NanOlogy. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
LSAM-Cisplatin
03
Conditions
diffuse midline glioma (DMG)diffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT07767110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07767110.